Cargando…

Tumor Cells Develop Defined Cellular Phenotypes After 3D-Bioprinting in Different Bioinks

Malignant melanoma is often used as a model tumor for the establishment of novel therapies. It is known that two-dimensional (2D) culture methods are not sufficient to elucidate the various processes during cancer development and progression. Therefore, it is of major interest to establish defined b...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Sonja K., Schmid, Rafael, Arkudas, Andreas, Kengelbach-Weigand, Annika, Bosserhoff, Anja K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829876/
https://www.ncbi.nlm.nih.gov/pubmed/31652536
http://dx.doi.org/10.3390/cells8101295
_version_ 1783465660894937088
author Schmidt, Sonja K.
Schmid, Rafael
Arkudas, Andreas
Kengelbach-Weigand, Annika
Bosserhoff, Anja K.
author_facet Schmidt, Sonja K.
Schmid, Rafael
Arkudas, Andreas
Kengelbach-Weigand, Annika
Bosserhoff, Anja K.
author_sort Schmidt, Sonja K.
collection PubMed
description Malignant melanoma is often used as a model tumor for the establishment of novel therapies. It is known that two-dimensional (2D) culture methods are not sufficient to elucidate the various processes during cancer development and progression. Therefore, it is of major interest to establish defined biofabricated three-dimensional (3D) models, which help to decipher complex cellular interactions. To get an impression of their printability and subsequent behavior, we printed fluorescently labeled melanoma cell lines with Matrigel and two different types of commercially available bioinks, without or with modification (RGD (Arginine-Glycine-Aspartate)-sequence/laminin-mixture) for increased cell-matrix communication. In general, we demonstrated the printability of melanoma cells in all tested biomaterials and survival of the printed cells throughout 14 days of cultivation. Melanoma cell lines revealed specific differential behavior in the respective inks. Whereas in Matrigel, the cells were able to spread, proliferate and form dense networks throughout the construct, the cells showed no proliferation at all in alginate-based bioink. In gelatin methacrylate-based bioink, the cells proliferated in clusters. Surprisingly, the modifications of the bioinks with RGD or the laminin blend did not affect the analyzed cellular behavior. Our results underline the importance of precisely adapting extracellular matrices to individual requirements of specific 3D bioprinting applications.
format Online
Article
Text
id pubmed-6829876
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-68298762019-11-18 Tumor Cells Develop Defined Cellular Phenotypes After 3D-Bioprinting in Different Bioinks Schmidt, Sonja K. Schmid, Rafael Arkudas, Andreas Kengelbach-Weigand, Annika Bosserhoff, Anja K. Cells Article Malignant melanoma is often used as a model tumor for the establishment of novel therapies. It is known that two-dimensional (2D) culture methods are not sufficient to elucidate the various processes during cancer development and progression. Therefore, it is of major interest to establish defined biofabricated three-dimensional (3D) models, which help to decipher complex cellular interactions. To get an impression of their printability and subsequent behavior, we printed fluorescently labeled melanoma cell lines with Matrigel and two different types of commercially available bioinks, without or with modification (RGD (Arginine-Glycine-Aspartate)-sequence/laminin-mixture) for increased cell-matrix communication. In general, we demonstrated the printability of melanoma cells in all tested biomaterials and survival of the printed cells throughout 14 days of cultivation. Melanoma cell lines revealed specific differential behavior in the respective inks. Whereas in Matrigel, the cells were able to spread, proliferate and form dense networks throughout the construct, the cells showed no proliferation at all in alginate-based bioink. In gelatin methacrylate-based bioink, the cells proliferated in clusters. Surprisingly, the modifications of the bioinks with RGD or the laminin blend did not affect the analyzed cellular behavior. Our results underline the importance of precisely adapting extracellular matrices to individual requirements of specific 3D bioprinting applications. MDPI 2019-10-22 /pmc/articles/PMC6829876/ /pubmed/31652536 http://dx.doi.org/10.3390/cells8101295 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Schmidt, Sonja K.
Schmid, Rafael
Arkudas, Andreas
Kengelbach-Weigand, Annika
Bosserhoff, Anja K.
Tumor Cells Develop Defined Cellular Phenotypes After 3D-Bioprinting in Different Bioinks
title Tumor Cells Develop Defined Cellular Phenotypes After 3D-Bioprinting in Different Bioinks
title_full Tumor Cells Develop Defined Cellular Phenotypes After 3D-Bioprinting in Different Bioinks
title_fullStr Tumor Cells Develop Defined Cellular Phenotypes After 3D-Bioprinting in Different Bioinks
title_full_unstemmed Tumor Cells Develop Defined Cellular Phenotypes After 3D-Bioprinting in Different Bioinks
title_short Tumor Cells Develop Defined Cellular Phenotypes After 3D-Bioprinting in Different Bioinks
title_sort tumor cells develop defined cellular phenotypes after 3d-bioprinting in different bioinks
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829876/
https://www.ncbi.nlm.nih.gov/pubmed/31652536
http://dx.doi.org/10.3390/cells8101295
work_keys_str_mv AT schmidtsonjak tumorcellsdevelopdefinedcellularphenotypesafter3dbioprintingindifferentbioinks
AT schmidrafael tumorcellsdevelopdefinedcellularphenotypesafter3dbioprintingindifferentbioinks
AT arkudasandreas tumorcellsdevelopdefinedcellularphenotypesafter3dbioprintingindifferentbioinks
AT kengelbachweigandannika tumorcellsdevelopdefinedcellularphenotypesafter3dbioprintingindifferentbioinks
AT bosserhoffanjak tumorcellsdevelopdefinedcellularphenotypesafter3dbioprintingindifferentbioinks